| Donald E. Morel Jr., Ph.D.
|
| Chairman of the Board, Chief Executive Officer
|
|
|
Age: 51
Bio & Compensation - Reuters
|
| Steven A. Ellers
|
| President
|
|
|
Age: 58
Bio & Compensation - Reuters
|
| William J. Federici
|
| Chief Financial Officer, Vice President
|
|
|
Age: 49
Bio & Compensation - Reuters
|
| Robert S. Hargesheimer
|
| President - Tech Group
|
|
|
Age: 51
Bio & Compensation - Reuters
|
| Donald A. McMillan
|
| President, Americas - Pharmaceutical Systems Division
|
|
|
Age: 50
Bio & Compensation - Reuters
|
| Fabio De Sampaio Dorio Filho
|
| President - Pharmaceutical Systems Division, Europe and Asia Pacific
|
|
|
Age: 45
Bio & Compensation - Reuters
|
| Matthew T. Mullarkey
|
| Chief Operating Officer
|
|
|
Age: 46
Bio & Compensation - Reuters
|
| John R. Gailey III
|
| Vice President, General Counsel, Secretary
|
|
|
Age: 54
Bio & Compensation - Reuters
|
| Michael A. Anderson
|
| Vice President, Treasurer
|
|
|
Age: 53
Bio & Compensation - Reuters
|
| Joseph E. Abbott
|
| Vice President, Corporate Controller
|
|
|
Age: 56
Bio & Compensation - Reuters
|